Showing results (51-60 of 71) with videos related to
Sort By:
Pageof 8
Viruses|June 28, 2023
VSV-ΔG-Spike Candidate Vaccine Induces Protective Immunity and Protects K18-hACE2 Mice against SARS-CoV-2 VariantsYfat Yahalom-Ronen, Hadas Tamir, Sharon Melamed, et al.Biorxiv : the Preprint Server for Biology|March 22, 2022
Parsing the role of NSP1 in SARS-CoV-2 infectionTal Fisher, Avi Gluck, Krishna Narayanan, et al.International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|April 18, 2023
Predictors of reinfection with pre-Omicron and Omicron variants of concern among individuals who recovered from COVID-19 in the first year of the pandemicDani Cohen, Marina Izak, Evgeniy Stoyanov, et al.Frontiers in Bioengineering and Biotechnology|October 18, 2021
Monitoring Group Activity of Hamsters and Mice as a Novel Tool to Evaluate COVID-19 Progression, Convalescence, and rVSV-ΔG-Spike Vaccination EfficacySharon Melamed, Boaz Politi, Ettie Grauer, et al.The Journal of Infectious Diseases|August 16, 2021
Sensitive Immunodetection of Severe Acute Respiratory Syndrome Coronavirus 2 Variants of Concern 501Y.V2 and 501Y.V1Moria Barlev-Gross, Shay Weiss, Nir Paran, et al.Nature Communications|April 26, 2022
Genome-wide CRISPR screens identify GATA6 as a proviral host factor for SARS-CoV-2 via modulation of ACE2Ma'ayan Israeli, Yaara Finkel, Yfat Yahalom-Ronen, et al.Cell Reports|June 24, 2021
Identification of presented SARS-CoV-2 HLA class I and HLA class II peptides using HLA peptidomicsAdi Nagler, Shelly Kalaora, Chaya Barbolin, et al.Cell Reports|June 7, 2022
Parsing the role of NSP1 in SARS-CoV-2 infectionTal Fisher, Avi Gluck, Krishna Narayanan, et al.Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|September 12, 2020
Detection and infectivity potential of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) environmental contamination in isolation units and quarantine facilitiesAmir Ben-Shmuel, Tal Brosh-Nissimov, Itai Glinert, et al.Nature Communications|August 29, 2020
A panel of human neutralizing mAbs targeting SARS-CoV-2 spike at multiple epitopesTal Noy-Porat, Efi Makdasi, Ron Alcalay, et al.Pageof 8